Xebra Brands will produce and market cannabis products
The Mexican subsidiary of the producer and marketer of cannabis-derived products, Xebra Brands, will invest around 3...
Baja California, Mexico, would be promoted as a technological platform for the biomedical industry
Entrepreneurs and representatives of the Government of Baja California are pursuing a project to position the state...
Pierre Fabre announces new CEOs for Mexico and Brazil
The Pierre Fabre Group announced Philippe De Carvalho, current CEO, as the new General Manager at the...
92% of medicines sold in Mexico are generic
Of the total medicines sold in Mexico, 92.6 percent are generic, which is relevant since their production...
T-MEC and ‘nearshoring’ can increase exports to the US: Bancomext
The general director of Nafin-Bancomext, Luis Antonio Ramírez, pointed out that they have identified several opportunities that...
SFP disqualifies pharmaceutical companies for monopolistic practices
The Ministry of Public Administration (SFP) communicated to dependencies and entities of the Federal Public Administration, to...
COFEPRIS presents a new Virtual Judgment Unit
Authorities of the Federal Commission for the Protection against Sanitary Risks (COFEPRIS) received a delegation from the...
INSABI detects 51 companies that distribute counterfeit medicines to the health sector
The general director of the Health Institute for Welfare (INSABI), Juan Antonio Ferrer Aguilar, assured that the...
Solo Salud will supply anti-Covid drugs excluding the private sector
Even though 80 people die every day from Covid-19 in Mexico, the Ministry of Health decided to...
COFEPRIS warns about counterfeit drugs against cancer and types 2 diabetes
The Federal Commission for the Protection against Sanitary Risks (COFEPRIS) issued an alert about the counterfeiting of...